Finasteride 5 MG Oral Tablet
1 INDICATIONS AND USAGE Finasteride, is a 5α-reductase inhibitor, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to ( 1.1 ): Improve symptoms Reduce the risk of acute urinary retention Reduce the risk of the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy. Finasteride administered in combination with the alpha-blocker doxazosin is indicated to reduce the risk of symptomatic progression of BPH (a confirmed ≥4 point increase in American Urological Association (AUA) symptom score) ( 1.2 ). Limitations of Use : Finasteride is not approved for the prevention of prostate cancer ( 1.3 ). 1.1 Monotherapy Finasteride tablets 5 mg are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: -Improve symptoms -Reduce the risk of acute urinary retention -Reduce the risk of the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy. 1.2 Combination with Alpha-Blocker Finasteride tablets 5 mg administered in combination with the alpha-blocker doxazosin is indicated to reduce the risk of symptomatic progression of BPH (a confirmed ≥4 point increase in American Urological Association (AUA) symptom score). 1.3 Limitations of Use Finasteride is not approved for the prevention of prostate cancer.
Accord Healthcare, Inc.
ROUND BLUE F5
Related Pills
Fluvoxamine Maleate 50 MG Oral Tablet
Apotex Corp
Fluoxetine 60 MG Oral Tablet
Lupin Pharmaceuticals, Inc.
Fluvoxamine Maleate 50 MG Oral Tablet
Apotex Corp
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
FINASTERIDE tablets, USP 5 mg : blue, 7 mm, round, biconvex, film coated tablets, marked 'F5' on one side and plain on other side. They are supplied as follows: NDC 16729-090-10 Bottles of 30 with child resistant closure NDC 16729-090-15 Bottles of 90 with child resistant closure NDC 16729-090-01 Bottles of 100 with child resistant closure NDC 16729-090-16 Bottles of 500 NDC 16729-090-17 Bottles of 1000 Storage and Handling Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and keep container tightly closed. Females should not handle crushed or broken
FINASTERIDE tablets, USP 5mg when they are pregnant or may potentially be pregnant because of the possibility of absorption of
FINASTERIDE and the subsequent potential risk to a male fetus [see Warnings and Precautions (5.3) , and Use in Specific Populations (8.1) ] .
More pills like ROUND F5